News und Analysen
AbraSilver Announces Exploration Drilling Results at JAC Zone and La Coipita Project; JAC Results Include 3 Metres at 2,070 g/t Ag
La Coipita Drill Hole Returned a Broad Intercept Totaling 694 Metres at 0.16% Cu and 81 ppm Mo
Toronto - July 12, 2023: AbraSilver Resource Corp. (TSX.V: ABRA; OTCQX: ABBRF) ("AbraSilver"
3 Hotel Stocks Earning Five Star Ratings From Markets In July
Markets can have their pick-and-choose cycles for their favored sectors in the economy. The hotel and accommodation spaces are among the few sectors pushing the U.S. economy forward, despite FED
3 Space Stocks That Could Take Off Like a Rocket
The space industry is big business, and it will only get bigger. According to Grand View Research, the global space tourism market was valued at $695.1 million in 2022. However, it’s expected to
Netflix Can Soar Higher In The 2nd Half
Netflix (NASDAQ: NFLX) made some big changes over the last year, but the signs are good that those changes are working for the better. The combination of password-sharing initiatives and
Netflix Can Soar Higher In The 2nd Half
Netflix (NASDAQ: NFLX) made some big changes over the last year, but the signs are good that those changes are working for the better. The combination of password-sharing initiatives and
3 Biotech Stocks to Buy for Long-Term Gains
Suppose you’re looking for a sector that will benefit from an end to the Federal Reserve’s interest rate hiking campaign. In that case, you may look at biotech stocks, a sector filled with
3 Biotech Stocks to Buy for Long-Term Gains
Suppose you’re looking for a sector that will benefit from an end to the Federal Reserve’s interest rate hiking campaign. In that case, you may look at biotech stocks, a sector filled with
3 Biotech Stocks to Buy for Long-Term Gains
Suppose you’re looking for a sector that will benefit from an end to the Federal Reserve’s interest rate hiking campaign. In that case, you may look at biotech stocks, a sector filled with
Netflix Can Soar Higher In The 2nd Half
Netflix (NASDAQ: NFLX) made some big changes over the last year, but the signs are good that those changes are working for the better. The combination of password-sharing initiatives and
Sensationeller Erfolg im Kampf gegen Hautkrebs - Massives Kaufsignal. Neuer 206% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). Jetzt 206% mit Biotech Hot Stock
Sensationeller Erfolg im Kampf gegen Hautkrebs - Massives Kaufsignal. 206% Biotech Aktientip nach 134.452% mit Biogen
13.07.23 08:18
London (www.aktiencheck.de, Anzeige)
Sensationeller Erfolg im Kampf gegen Hautkrebs - Massives Kaufsignal. Neuer 206% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). Jetzt 206% mit Biotech Hot Stock
Sensationeller Erfolg im Kampf gegen Hautkrebs - Massives Kaufsignal. 206% Biotech Aktientip nach 134.452% mit Biogen
13.07.23 08:18
London (www.aktiencheck.de, Anzeige)
Sensationeller Erfolg im Kampf gegen Hautkrebs - Massives Kaufsignal. Neuer 206% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). Jetzt 206% mit Biotech Hot Stock
Sensationeller Erfolg im Kampf gegen Hautkrebs - Massives Kaufsignal. 206% Biotech Aktientip nach 134.452% mit Biogen
13.07.23 08:18
London (www.aktiencheck.de, Anzeige)
Contrarian Play: Beyond Meat Is At An Inflection Point
Beyond Meat (NASDAQ: BYND) deserves its spot among the most shorted stocks on Wall Street, but the story is played. The company’s attempt to enter the mainstream market via fast food was a flop
Contrarian Play: Beyond Meat Is At An Inflection Point
Beyond Meat (NASDAQ: BYND) deserves its spot among the most shorted stocks on Wall Street, but the story is played. The company’s attempt to enter the mainstream market via fast food was a flop
Contrarian Play: Beyond Meat Is At An Inflection Point
Beyond Meat (NASDAQ: BYND) deserves its spot among the most shorted stocks on Wall Street, but the story is played. The company’s attempt to enter the mainstream market via fast food was a flop
This Small Cap Stock Surged Over 100%
Arguably the most impressive mover yesterday was a stock you have probably never heard of. Shares of Eloxx Pharmaceuticals (NASDAQ: ELOX) rocketed almost 100% yesterday after receiving an
Activision Surges 10% As Judge OK's Microsoft Acquisition Deal
Activision Blizzard Inc. (NASDAQ: ATVI) shares rose to the call of duty on July 11, advancing 10.02% in heavy trading volume as a federal judge gave the OK for Microsoft Corp. (NASDAQ: MSFT) to
Activision Surges 10% As Judge OK's Microsoft Acquisition Deal
Activision Blizzard Inc. (NASDAQ: ATVI) shares rose to the call of duty on July 11, advancing 10.02% in heavy trading volume as a federal judge gave the OK for Microsoft Corp. (NASDAQ: MSFT) to
Activision Surges 10% As Judge OK's Microsoft Acquisition Deal
Activision Blizzard Inc. (NASDAQ: ATVI) shares rose to the call of duty on July 11, advancing 10.02% in heavy trading volume as a federal judge gave the OK for Microsoft Corp. (NASDAQ: MSFT) to
Erstklassige Studienergebnisse im Kampf gegen Hautkrebs - Massives Kaufsignal. Neuer 208% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Erstkl. Studienergebnisse im Kampf gegen Hautkrebs - Massives Kaufsignal. 208% Biotech Hot Stock nach 31.205% mit Amgen
12.07.23 08:02
London (www.aktiencheck.de, Anzeige)
Erstklassige Studienergebnisse im Kampf gegen Hautkrebs - Massives Kaufsignal. Neuer 208% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Erstkl. Studienergebnisse im Kampf gegen Hautkrebs - Massives Kaufsignal. 208% Biotech Hot Stock nach 31.205% mit Amgen
12.07.23 08:02
London (www.aktiencheck.de, Anzeige)
Erstklassige Studienergebnisse im Kampf gegen Hautkrebs - Massives Kaufsignal. Neuer 208% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Erstkl. Studienergebnisse im Kampf gegen Hautkrebs - Massives Kaufsignal. 208% Biotech Hot Stock nach 31.205% mit Amgen
12.07.23 08:02
London (www.aktiencheck.de, Anzeige)
Another Double-Digit Gain Is In Store For Salesforce
Shares of Salesforce.com (NASDAQ: CRM) are up about 70% from the first of the year, and another double-digit gain is in store. The company just announced the first price increase in years, and it
What are the 3 Best Bank Stocks This Earnings Season?
Earnings season kicks off this week. In a tried-and-true Wall Street ritual, bank stocks will be among the first to report. That means it’s time to look at which banks are likely to look like good
PriceSmart Pulls Back: A Smart Time To Buy Emerging Markets?
With emerging markets expected to diverge from developed markets in the 2nd half, PriceSmart (NASDAQ: PSMT) looks like an intelligent play. According to GlobalXETFs, low valuations and secular